House members push for CT Colonography NCD
This article was originally published in The Gray Sheet
Executive Summary
Six House members, led by Rep. Barbara Cubin, R-Wyo., want CMS to approve a national coverage determination for computed tomography colonography as a screening test for colorectal cancer - a proposal that the agency will be taking up at a Medicare Evidence Development & Coverage Advisory Committee meeting on Nov. 19 ("1The Gray Sheet" Nov. 3, 2008, p. 10). Cubin, along with Reps. Ed Towns, D-N.Y., Chip Pickering, R-Miss., Charlie Wilson, D-Ohio, John Sullivan, R-Okla., and Tammy Baldwin, D-Wis., told CMS in an Oct. 24 letter that allowing CTC, also known as "virtual colonoscopy," to be covered under an NCD would provide a cheaper alternative to traditional optical colonoscopies for patients and would result in more patients getting screened for cancer
You may also be interested in...
MedCAC To Ponder Cost Question At Virtual Colonoscopy Meeting
CMS wants an advisory board to consider the costs per life years saved for computed tomography colonography at a Nov. 19 meeting
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.